4.3 Article

Inducible PC12 cell model of Huntington's disease shows toxicity and decreased histone acetylation

Journal

NEUROREPORT
Volume 14, Issue 4, Pages 565-568

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00001756-200303240-00007

Keywords

CBP; histone acetyltransferase; huntingtin; Huntington's disease; PC12; polyglutamine

Categories

Funding

  1. NINDS NIH HHS [NS34144, NS34172, NS38377, NS16375] Funding Source: Medline

Ask authors/readers for more resources

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the abnormal expansion of a polyglutamine tract in the huntingtin protein. We have developed PC12 cell lines in which the expression of an N-terminal truncation of huntingtin (N63) with either wild type (23Q) or expanded polyglutamine (148Q) can be induced by the removal of doxycycline. Differentiated PC12 cells induced to express N63-148Q showed cellular toxicity reaching up to 50% at 6 days post-induction. Histone acetyltransferase (HAT) activity and global histone acetylation was significantly decreased in cells expressing truncated huntingtin with mutant but not normal huntingtin. These data suggest that altered chromatin modification via reduction in coactivator activity may cause neuronal transcriptional dysregulation and contribute to cellular toxicity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available